FinalDose · London
FinalDose's platform requires delivery solutions tailored to each therapeutic indication. You will lead delivery engineering across multiple administration routes, optimizing lipid nanoparticle formulations for tissue-specific targeting and therapeutic efficacy. Your work will bridge in vitro formulation development with in vivo validation and ultimately support technology transfer for GMP manufacturing. This is a critical role linking our construct engineering with clinical-stage drug products. Responsibilities Lead LNP delivery engineering across multiple administration routes, including local, systemic, and inhaled formulations Develop and optimize LNP formulations with full physicochemical characterization (DLS, encapsulation efficiency, zeta potential) Perform in vitro delivery optimization and hand off validated formulations to the in vivo team for animal studies Support CMO/CDMO selection and technology transfer for GMP-grade manufacturing Collaborate with biology teams to evaluate delivery efficiency using functional readouts (editing efficiency, reporter assays) in cell lines and primary cells Required Ph.D. in pharmaceutical sciences, drug delivery, biomedical engineering, or chemical engineering 3–5+ years of hands-on experience with lipid nanoparticle formulation Demonstrated expertise in at least two of the following: mRNA-LNP encapsulation and delivery, tissue-targeted delivery (SORT technology or ionizable lipid screening), inhaled or pulmonary drug delivery Experience with microfluidic mixing and formulation scale-up In vitro delivery characterization in cell lines and primary cells Preferred Experience with intravesical or local drug delivery CMC or technology transfer experience with a CDMO Air-liquid interface (ALI) culture and aerosol delivery expertise Awareness of GMP manufacturing processes and requirements